WO1983001002A1 - Quaternary ammonium group-containing polymers having antimicrobial activity - Google Patents

Quaternary ammonium group-containing polymers having antimicrobial activity Download PDF

Info

Publication number
WO1983001002A1
WO1983001002A1 PCT/US1982/001244 US8201244W WO8301002A1 WO 1983001002 A1 WO1983001002 A1 WO 1983001002A1 US 8201244 W US8201244 W US 8201244W WO 8301002 A1 WO8301002 A1 WO 8301002A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
composition
carbon
quaternary ammonium
alkyls
Prior art date
Application number
PCT/US1982/001244
Other languages
French (fr)
Inventor
Shareholders' Liquidating Trust Dynapol
Bernard G. Sheldon
Robert E. Wingard, Jr.
Ned M. Weinshenker
Daniel J. Dawson
Original Assignee
Dynapol Shareholders Liquidati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dynapol Shareholders Liquidati filed Critical Dynapol Shareholders Liquidati
Publication of WO1983001002A1 publication Critical patent/WO1983001002A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/745Polymers of hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen

Definitions

  • This invention relates to quaternary ammo nium group-containing polymers. More particularly it concerns a family of such polymers that exhibit antimicrobial activity and their application as antimicrobials.
  • the polymers of the invention may be classified as having a poly(vinylbenzyl quaternary ammonium) halide structure. In certain embodiments, they have a copolymer- structure with repeating
  • polymeric quaternary compounds fill a well identified and recognized need for a polymeric antimicrobial agent similar to or surpassing known nonpolymeric species such as hexachlorophene, Zephiran and the like.
  • a polymeric antimicrobial agent similar to or surpassing known nonpolymeric species such as hexachlorophene, Zephiran and the like.
  • the present materials are less mobile and less likely to migrate or inappropriately penetrate or be absorbed into substrates. This permits their use in environments where penetration or displacement or volatilization are problems. Further, it permits residual antimicrobial activity to be imparted to surfaces and the like by the use of these materials.
  • R is a 4 to 12 carbon atom alkyl and R' and R'' are each independently 1 to 4 carbon atom alkyls and X- is an anion such as halide, have antimicrobial activity.
  • Such materials can be homopolymers but preferably are "copolymers. These polymers and copoly mers constitute aspects of this invention. Antimicrobial compositions based on them and their use constitute additional aspects.
  • Molecular weights are expressed in daltons (D) and are determined by gel permeation chromatography comparison of experimental compounds with chemically similar standards of known molecular weight. Weights, temperatures and pressures are given in metric units unless otherwise noted.
  • “Hygienically acceptable” refers to the property of being acceptable as a component of a material to be used to clean, disinfect or sterilize a human's or animal's physiological environment.
  • “Physiologically acceptable” means non-toxic and usable in materials contacting or consumed by mammals including man.
  • Machine unit means a discrete repeating unit within the polymer structure.
  • the homopolymers and copolymers of this invention always contain a vinylbenzyl ammonium salt as a recurring mer unit. This unit has the structure
  • R ' X " wherein R is a 4 to 12 carbon alkyl and R' and R'' are the same or different 1 to 4 carbon atom alkyls.
  • X is a physiologically acceptable anion.
  • R is a 6 to 10 carbon atom linear or branched alkyl - i.e. hexyl, 2-ethylhexyl, octyl, decyl, nonyl, heptyl,
  • R' and R'' are 1 to 2 atom alkyls - that is methyl or ethyl. Usually and more preferably, R, and R'' are the same alkyl. The more preferred arrangement has R equal to an about 8 carbon atom alkyl. Most preferably R is n-octyl and R' and R'' are each methyl.
  • Counterion X- may be any physiologically acceptable anion.
  • usual preparative methods generally lead to a halide (e.g. Cl", I" or Br- ) with chloride ion being by far the most common.
  • the polymers contain copolymeric units - herein the generic structure being depicted as -CU-.
  • the units can be added for such down-to-earth purposes as to reduce the average cost per unit weight of the polymer or to "dilute" the active units and thus yield a more easily measured, handled or applied material.
  • the copolymeric units can be added to achieve or enhance desired physical properties, as well. Such properties include greater antimicrobial activity, better solubility in aqueous or nonaqueous media, better irascibility in various media, enhanced dispersibility, enhanced film forming and the like.
  • the first type of "CU” units are represented by styrene and similar vinylaromatics and lower alkenes or alkadienes such as ethylene, butadiene and the like.
  • the second type of CU units are illustrated by vinyl acetamide, vinyl amine, vinyl amine quater- nized with hydroxyethylenes or similar water solubil- izers or with a hydrophobe such as dodecyls, or vinylbenzyl amine quaternized with three long chain alkyl hydrophobes or with three lower alkyl or hydroxyalkyl hydrophiles.
  • Other units include for example vinyl acetate, vinyl alcohol, acrylic acid, acrylate and methacrylate esters; acrylamide and acrylamide derivatives including quaternized acrylamide; N-vinylimida- zole and derivatives thereof including quaternized N-vinylimidazoles; 4-vinylpyridine and derivatives thereof including quaternized 4-vinylpyridines ?
  • N-vinylpyrrolidone and derivatives thereof vinylbenzyl ethers of polyethylene glycols and their monoalkyl ethers. These units are all known in the art as are the methods for their incorporation into copolymers. Mixtures of two or more CU units may, of course, be used.
  • the CU's can be grouped as 2 to 6 carbon alkylenes or alkenylenes having pendent therefrom from 0 to 2 inclusive substituent groups selected from aryls, alkaryls, and aralkyls of 6-8 carbons, alkyls of 1-4 carbons, amides, hydroxyls, carboxylic acids, and their esters nitrogen-containing 5 or 6 atom heterocyclics and amine and ether-substituted aryls, alkaryls, and aralkyls.
  • copolymer units are vinylbenzyl -amines quaternized by hydrophilic groups such as hydroxy alkyls of from 1 to 4 carbon atoms, particularly vinylbenzyl amines quaternized with three 2-hydroxyethylenes (i.e. with a triethanolamine structure) .
  • hydrophilic groups such as hydroxy alkyls of from 1 to 4 carbon atoms, particularly vinylbenzyl amines quaternized with three 2-hydroxyethylenes (i.e. with a triethanolamine structure) .
  • Such units are represented structurally as
  • copolymer units are vinylbenzyl ethers of poly(ethyleneglycols) or their monoalkyl ethers, particularly methyl ethers. Such units are represented structurally as
  • the polymeric quaternary amines of this invention have at least about 10 mer units on average in each polymer molecule. Preferably they contain from 10 to about 2000 mer units. This gives rise to molecular weights for the homopolymer of from about 3000 to about 600,000 and for copolymers, of from about 1000 to a million or so, depending upon the unit and proportions employed. More preferably the number of mer units is from about 20 to about 1000.
  • the proportion of copolymeric mer units in the polymer can vary from 0 (homopolymer) to about 90% of the total. Among copolymers, those having at least about 20% of copolymer unit (CU's) are generally preferred. With less than this level, often the products have essentially the properties of the homopolymer. This means that structurally the polymers can be represented as follows:
  • R is a 4 to 12 carbon atom alkyl and R' and R'' are 1 to 4 carbon alkyls and n is 10 to 2000 and X is an anion; and (copolymer)
  • the polymers of this invention can be prepared by the general process of: a. polymerizing vinylbenzyl halide plus any optional comonomer units using free-radical catalysis, and b. reacting the resulting poly (vinylbenzyl halide) with tertiary amine to yield the desired quaternary amine which is thereafter recovered.
  • the polymerization reaction is carried out with the monomer (s) in solution in an inert organic, often aromatic reaction medium such as toluene, benzene, tetrahydrofuran, or methylethyl ketone. It is of advantage to have an inert atmosphere, such as argon, over the reaction zone.
  • a free-radical initiator such as a peroxide, or for example, AIBN (azobisisobutyronitrile) is employed in amounts of from 0.01 to 0.5% wt (basis monomer).
  • the reaction is carried out at elevated temperatures, for example at temperatures of from 50 to 150°C, most commonly at the reflux temperature of the reaction medium. Elevated pressures may be employed to achieve temperatures above atmospheric reflux.
  • the reaction takes a substantial period - often as long as several days. Of course, this period is related .to the temperature employed with higher temperature requiring shorter time and lower temperature requiring longer times. As a guideline, at 75-80 °C reaction temperature the reaction is complete in 18 to 24 hours.
  • the polymeric intermediate product is recovered such as by precipitation following nonsolvent addition.
  • the rnolecular weight of the resulting polymer can be varied by changing reaction conditions, such as the monomer and free radical initiator concentrations, solvent composition, and the reaction temperature as is known in the art.
  • the coupling of the tertiary amine to the poly(vinylbenzyl halide) is carried out in a relatively polar organic solvent system such as THF or alkanols or mixtures thereof.
  • a relatively polar organic solvent system such as THF or alkanols or mixtures thereof.
  • solvent systems are tetrahydrofuran (THF), methanol, ethanol, isopropanol, isobutanol, THF:ethanol, THF:isopropanol, and THF: isobutanol.
  • THF tetrahydrofuran
  • methanol ethanol
  • isopropanol isobutanol
  • THF:ethanol ethanol
  • THF isobutanol.
  • a preferred solvent system is 1:1 THF: isopropanol.
  • the reaction is carried out by admixing the poly(vinylbenzyl halide) and the tertiary amine in the reaction medium and heating.
  • the amount of tertiary amine should be controlled. If a homopolymer product is desired - i.e. with all available benzyl halide groups reacted — it is of advantage to add an excess of amine, such as from above 1.0 to 1.5 or more equivalents of amine per mole of available benzyl halide. The excess is employed only to speed the reaction. In fact, the amine will react relatively quantitatively with available halide sites.
  • tertiary amine when it is desired to react only a portion of the available halide sites with tertiary amine, less tertiary amine should be added.
  • tertiary amine when a 1:1 equivalent tertiary amine: trialkanol amine copolymer is desired, one generally adds about 0.5 equivalent of trialkyl amine, basis available sites.
  • This reaction is complete in 24 hours at 60-80 °C .
  • the reactants are relatively heat stable so higher temperatures such as up to 150°C can be employed without adversely affecting the reaction ' s yield.
  • temperatures from about 50 to 150 °C and times of 1 to 24 hours can be employed with temperatures of 60 to 140oC being preferred.
  • reactants with the benzyl halide sites for example trialkanolamines
  • the coupling of the second material may be carried out in the same reaction medium without intermediate isolation of the product.
  • the coupling of the second material generally employs similar reac tion conditions to those used to couple the first.
  • the polymers of this invention are characterized as having antimicrobial activity. In this use they are formulated into antimicrobial compositions such as by being admixed with an hygienically accep- table carrier or vehicle.
  • This antimicrobial activity gives the materials utility as preservatives for ophthalmic, solutions, especially wetting solutions, .cleaning solutions, cushioning solutions and soaking solutions for hard and soft contact lenses.
  • the materials offer a special advantage of not absorbing and concentrating within the lens as roonomeric antimicrobials and preservaties have been known. to do.
  • Other utilities are as preserva tives and/or antimicrobials for hair care, and topical pharmaceutical products.
  • Other uses include incorporation in intra-vaginal anti-infectives, spermicides, therapeutic skin care (anti-acne) preparations and use as persistent deodorants or antimicrobials for body cavities such as the abdomen, lungs, or GI tract and the like.
  • the products can he formulated with various cleanser components to form persistent disinfectants for home or hospital use.
  • the products are generally admixed with a suitable carrier or medium such as sterile water or saline, gel salve bases, and the like in an antimicrobially effective amount which amount is defined to be an amount sufficient to effect the desired antimicrobial or preserving action.
  • a suitable carrier or medium such as sterile water or saline, gel salve bases, and the like
  • antimicrobially effective amount which amount is defined to be an amount sufficient to effect the desired antimicrobial or preserving action.
  • Such amounts vary from as little as 10 - 20 ppm to as much as 1000 ppm (in finished product form) or up to 5% in concentrated formulations.
  • the antimicrobial formulations are prepared by conventional means of admixing, grinding and the like.
  • the polymers can be considered to be like other water-soluble salts and may be treated accordingly. No special formulation techiques are usually required.
  • a taffy-like precipitate formed was collected, was rinsed in water, redissolved in THF, filtered, precipitated in petroleum ether, redissolved in THF and finally precipitated in methanol. The precipitate was collected and vacuum dried for nine hours at 60°C.
  • the product was a powder having an average molecular weight by qel permeation chromatography comparison with polystyrene of 6.4 X 10 3 .
  • Triethanolamine (2.0 g, 13.4 mmole) was added to the reaction product of Part B, followed by 30 ml of isopropanol. The reaction mixture was then refluxed another 24 hours. At the conclusion of this reaction period, the homogeneous mixture was cooled, diluted to three times its original volume with water, and the volatile constituents removed by in vacuo distillation (rotary evaporator). The residue, after concentration to one-half volume, was diluted with three volumes of 20% aqueous isopropanol and .ultrafiltered through a 10,000 molecular-weight-cutoff cartridge (Amicon H1P10) with ten diavolumes of deionized water. The retentate was then concentrated by ultrafiltration to 100 ml and lyophilized to yield 2.46 g fluffy white solid of the formula
  • Example I The preparation of Example I was repeated substituting for dimethyloctylamine in equivalent amounts as follows:
  • Example I 0.5 ratio vinylbenzylchloride: n-dodecyl-4 vinyl pyridinium chloride M.
  • the preparation of Example I is repeated substituting trimethylamine for triethanolamine.
  • a typical antimicrobial solution is prepared by dissolving 0.5% by weight of the product of Example I in sterile water, in a 25%/75% isopropanol/sterile water mixture, in a sterile saline solution adjusted to give isotonicity, and in an isotonic contact lens wetting solution containing 1% by weight poly(vinylalcohol).
  • An antimicrobial cleansing composition comprising 10% of the dry polymer of Example II and 90% powdered surfactant is prepared. When this composition is dissolved in water an antimicrobial solution results .
  • An antimicrobial salve is formulated by admixing 1% of the powder of Example I in a pharmaceutically acceptable poly saccharride gel.
  • Example I, II, III, IV, V, and VI were tested for antimicrobial activity.
  • Zephiran ⁇ a commercially accepted antimicrobial
  • comparative materials 1, 2 and 3 were also evaluated. Two basic test methods were used.
  • MIC Minimum Inhibition Concentration
  • Example III >250 >48
  • Example IV ⁇ 50 0.17
  • Example V ⁇ 100 0.6
  • Example VI ⁇ 250 4 Comparative 1 >250 >48 Comparative 2 >250 >48 Comparative 3 >250 24

Abstract

Polymeric quaternary ammonium compounds having recurring vinylbenzyl ammonium units. The quaternary ammonium units preferably have 2 alkyl substituents of 1 to 4 carbons and 1 alkyl substituent of 4 to 12 carbons and thus comprise repeat units of the structure <IMAGE> wherein R is a 4 to 12 carbon alkyl, R' and R'' are each 1 to 4 carbon alkyls and X<-> is an anion. These materials have antimicrobial properties and are particularly useful for preserving ophthalmic solutions.

Description

QUATERNARY AMMONIUM GROUP-CONTAINING POLYMERS HAVING ANTIMICROBIAL ACTIVITY
Field of the Invention
This invention relates to quaternary ammo nium group-containing polymers. More particularly it concerns a family of such polymers that exhibit antimicrobial activity and their application as antimicrobials.
Background Art Quaternary ammonium group-containing polymers have been widely studied. A review of the literature has turned up a vast collection of references to the general subject. As this invention relates to quaternary ammonium polymeric compounds having antimicrobial activity as well as to certain new copolymeric quaternary polymers, three references to Green et al may be of interest. These references, USP's 3,931,319; 4,005,193; and 4,025,617, disclose polymeric quaternary ammonium polymers having antimicrobial activity. However, Green et al's polymers are structurally dissimilar to the present materials.
The polymers of the invention may be classified as having a poly(vinylbenzyl quaternary ammonium) halide structure. In certain embodiments, they have a copolymer- structure with repeating
Figure imgf000003_0001
X- = physiologically acceptable anion
R's = alkyls q = 1 to 4, preferably 2 units. USP's 2,702,795 of Gilwood; 2,772,310 of
Morris; 3,563,949 of Hartenstein and 4,087,599 of Roe et al, as well as Journal of Polymer Science, Polymer Chemistry Edition, Vol. 18, pp. 455-65, 619-80, Dragan et al, are certainly of interest as they show similar groups but do not suggest the present materials.
These polymeric quaternary compounds fill a well identified and recognized need for a polymeric antimicrobial agent similar to or surpassing known nonpolymeric species such as hexachlorophene, Zephiran and the like. Being large polymeric molecules, the present materials are less mobile and less likely to migrate or inappropriately penetrate or be absorbed into substrates. This permits their use in environments where penetration or displacement or volatilization are problems. Further, it permits residual antimicrobial activity to be imparted to surfaces and the like by the use of these materials.
Disclosure of Invention
It has now been discovered that polymeric quaternary amines having recurring vinylbenzyl ammonium groups of the structure
Figure imgf000005_0001
wherein R is a 4 to 12 carbon atom alkyl and R' and R'' are each independently 1 to 4 carbon atom alkyls and X- is an anion such as halide, have antimicrobial activity. Such materials can be homopolymers but preferably are "copolymers. These polymers and copoly mers constitute aspects of this invention. Antimicrobial compositions based on them and their use constitute additional aspects.
Modes for Carrying Out the Invention The term "recurring" when used herein to describe mer units of a polymer is an inclusive term to describe homopolymers and copolymers with or without added copolymer units.
Molecular weights are expressed in daltons (D) and are determined by gel permeation chromatography comparison of experimental compounds with chemically similar standards of known molecular weight. Weights, temperatures and pressures are given in metric units unless otherwise noted. "Hygienically acceptable" refers to the property of being acceptable as a component of a material to be used to clean, disinfect or sterilize a human's or animal's physiological environment.
"Physiologically acceptable" means non-toxic and usable in materials contacting or consumed by mammals including man.
"Mer unit" means a discrete repeating unit within the polymer structure.
The homopolymers and copolymers of this invention always contain a vinylbenzyl ammonium salt as a recurring mer unit. This unit has the structure
R ' X"
Figure imgf000006_0001
wherein R is a 4 to 12 carbon alkyl and R' and R'' are the same or different 1 to 4 carbon atom alkyls. X is a physiologically acceptable anion. Preferably R is a 6 to 10 carbon atom linear or branched alkyl - i.e. hexyl, 2-ethylhexyl, octyl, decyl, nonyl, heptyl,
2,4-dimethylhexyl and the like. Also preferably R' and R'' are 1 to 2 atom alkyls - that is methyl or ethyl. Usually and more preferably, R, and R'' are the same alkyl. The more preferred arrangement has R equal to an about 8 carbon atom alkyl. Most preferably R is n-octyl and R' and R'' are each methyl.
Counterion X- may be any physiologically acceptable anion. However, usual preparative methods generally lead to a halide (e.g. Cl", I" or Br- ) with chloride ion being by far the most common.
Optionally and preferably the polymers contain copolymeric units - herein the generic structure being depicted as -CU-. The units can be added for such down-to-earth purposes as to reduce the average cost per unit weight of the polymer or to "dilute" the active units and thus yield a more easily measured, handled or applied material. The copolymeric units can be added to achieve or enhance desired physical properties, as well. Such properties include greater antimicrobial activity, better solubility in aqueous or nonaqueous media, better irascibility in various media, enhanced dispersibility, enhanced film forming and the like.
The first type of "CU" units are represented by styrene and similar vinylaromatics and lower alkenes or alkadienes such as ethylene, butadiene and the like. The second type of CU units are illustrated by vinyl acetamide, vinyl amine, vinyl amine quater- nized with hydroxyethylenes or similar water solubil- izers or with a hydrophobe such as dodecyls, or vinylbenzyl amine quaternized with three long chain alkyl hydrophobes or with three lower alkyl or hydroxyalkyl hydrophiles. Other units include for example vinyl acetate, vinyl alcohol, acrylic acid, acrylate and methacrylate esters; acrylamide and acrylamide derivatives including quaternized acrylamide; N-vinylimida- zole and derivatives thereof including quaternized N-vinylimidazoles; 4-vinylpyridine and derivatives thereof including quaternized 4-vinylpyridines ?
N-vinylpyrrolidone and derivatives thereof; vinylbenzyl ethers of polyethylene glycols and their monoalkyl ethers. These units are all known in the art as are the methods for their incorporation into copolymers. Mixtures of two or more CU units may, of course, be used.
Generically, the CU's can be grouped as 2 to 6 carbon alkylenes or alkenylenes having pendent therefrom from 0 to 2 inclusive substituent groups selected from aryls, alkaryls, and aralkyls of 6-8 carbons, alkyls of 1-4 carbons, amides, hydroxyls, carboxylic acids, and their esters nitrogen-containing 5 or 6 atom heterocyclics and amine and ether-substituted aryls, alkaryls, and aralkyls.
One preferred group of copolymer units are vinylbenzyl -amines quaternized by hydrophilic groups such as hydroxy alkyls of from 1 to 4 carbon atoms, particularly vinylbenzyl amines quaternized with three 2-hydroxyethylenes (i.e. with a triethanolamine structure) . Such units are represented structurally as
X-
Figure imgf000008_0001
wherein q is 2 through 4 inclusive and most preferably 2.
Another preferred group of copolymer units are vinylbenzyl ethers of poly(ethyleneglycols) or their monoalkyl ethers, particularly methyl ethers. Such units are represented structurally as
Figure imgf000008_0002
wherein y is 1 through 10 inclusive, preferably 1 through 4 inclusive, and R''' is a hydrogen or lower alkyl unit, such as from 1 to 4 carbons most generally methyl. The polymeric quaternary amines of this invention have at least about 10 mer units on average in each polymer molecule. Preferably they contain from 10 to about 2000 mer units. This gives rise to molecular weights for the homopolymer of from about 3000 to about 600,000 and for copolymers, of from about 1000 to a million or so, depending upon the unit and proportions employed. More preferably the number of mer units is from about 20 to about 1000.
The proportion of copolymeric mer units in the polymer can vary from 0 (homopolymer) to about 90% of the total. Among copolymers, those having at least about 20% of copolymer unit (CU's) are generally preferred. With less than this level, often the products have essentially the properties of the homopolymer. This means that structurally the polymers can be represented as follows:
(homopolymer)
Figure imgf000009_0001
wherein R is a 4 to 12 carbon atom alkyl and R' and R'' are 1 to 4 carbon alkyls and n is 10 to 2000 and X is an anion; and (copolymer)
Figure imgf000010_0001
wherein the R's and X and n are as set forth, m + p = n, p = 0 to 0.9(n) preferably 0.2 to 0.9(n) and CU is a copolymeric unit.
The two preferred families of copolymers are represented by
Figure imgf000010_0002
wherein m + p = n, q is 2 through 4 inclusive, and the R's and X- are as defined; and especially when R is octyl and R' and R'' are each methyls, q is 2 and n is 20 to 100 and p is about 0.3 n; and
Figure imgf000010_0003
wherein m, p, X- and R' R', and R'' are as defined and y is 1 to 10 preferably 1 through 4 inclusive and R' ' ' is hydrogen or lower alkyl of 1 through 4 carbons, especially methyl. The polymers of this invention can be prepared by the general process of: a. polymerizing vinylbenzyl halide plus any optional comonomer units using free-radical catalysis, and b. reacting the resulting poly (vinylbenzyl halide) with tertiary amine to yield the desired quaternary amine which is thereafter recovered.
In a representative preparation, the polymerization reaction is carried out with the monomer (s) in solution in an inert organic, often aromatic reaction medium such as toluene, benzene, tetrahydrofuran, or methylethyl ketone. It is of advantage to have an inert atmosphere, such as argon, over the reaction zone. A free-radical initiator such as a peroxide, or for example, AIBN (azobisisobutyronitrile) is employed in amounts of from 0.01 to 0.5% wt (basis monomer). The reaction is carried out at elevated temperatures, for example at temperatures of from 50 to 150°C, most commonly at the reflux temperature of the reaction medium. Elevated pressures may be employed to achieve temperatures above atmospheric reflux. The reaction takes a substantial period - often as long as several days. Of course, this period is related .to the temperature employed with higher temperature requiring shorter time and lower temperature requiring longer times. As a guideline, at 75-80 °C reaction temperature the reaction is complete in 18 to 24 hours. The polymeric intermediate product is recovered such as by precipitation following nonsolvent addition. The rnolecular weight of the resulting polymer can be varied by changing reaction conditions, such as the monomer and free radical initiator concentrations, solvent composition, and the reaction temperature as is known in the art.
The coupling of the tertiary amine to the poly(vinylbenzyl halide) is carried out in a relatively polar organic solvent system such as THF or alkanols or mixtures thereof. Examples of such solvent systems are tetrahydrofuran (THF), methanol, ethanol, isopropanol, isobutanol, THF:ethanol, THF:isopropanol, and THF: isobutanol. A preferred solvent system is 1:1 THF: isopropanol.
The reaction is carried out by admixing the poly(vinylbenzyl halide) and the tertiary amine in the reaction medium and heating. The amount of tertiary amine should be controlled. If a homopolymer product is desired - i.e. with all available benzyl halide groups reacted — it is of advantage to add an excess of amine, such as from above 1.0 to 1.5 or more equivalents of amine per mole of available benzyl halide. The excess is employed only to speed the reaction. In fact, the amine will react relatively quantitatively with available halide sites. Thus, when it is desired to react only a portion of the available halide sites with tertiary amine, less tertiary amine should be added. For example, when a 1:1 equivalent tertiary amine: trialkanol amine copolymer is desired, one generally adds about 0.5 equivalent of trialkyl amine, basis available sites.
This reaction is complete in 24 hours at 60-80 °C . The reactants are relatively heat stable so higher temperatures such as up to 150°C can be employed without adversely affecting the reaction ' s yield. Thus temperatures from about 50 to 150 °C and times of 1 to 24 hours can be employed with temperatures of 60 to 140ºC being preferred.
Other reactants with the benzyl halide sites, for example trialkanolamines, can be added together with the trialkylamine or sequentially. If two materials are added at the same time, one must be careful not to add an excess of the more reactive material or else the reaction will not give the stoi chiometry desired. Usually two materials are added sequentially. The coupling of the second material may be carried out in the same reaction medium without intermediate isolation of the product. The coupling of the second material generally employs similar reac tion conditions to those used to couple the first.
After coupling, it is desirable to purify the final product to remove excess amines, salts and the like. Dialysis, ultrafiltration and other artknown processes for isolating and purifying polymers can be employed.
The polymers of this invention are characterized as having antimicrobial activity. In this use they are formulated into antimicrobial compositions such as by being admixed with an hygienically accep- table carrier or vehicle.
This antimicrobial activity gives the materials utility as preservatives for ophthalmic, solutions, especially wetting solutions, .cleaning solutions, cushioning solutions and soaking solutions for hard and soft contact lenses. In the case of soft contact lenses, the materials offer a special advantage of not absorbing and concentrating within the lens as roonomeric antimicrobials and preservaties have been known. to do. Other utilities are as preserva tives and/or antimicrobials for hair care, and topical pharmaceutical products. Other uses include incorporation in intra-vaginal anti-infectives, spermicides, therapeutic skin care (anti-acne) preparations and use as persistent deodorants or antimicrobials for body cavities such as the abdomen, lungs, or GI tract and the like. In addition, the products can he formulated with various cleanser components to form persistent disinfectants for home or hospital use. In these applications, the products are generally admixed with a suitable carrier or medium such as sterile water or saline, gel salve bases, and the like in an antimicrobially effective amount which amount is defined to be an amount sufficient to effect the desired antimicrobial or preserving action. Such amounts vary from as little as 10 - 20 ppm to as much as 1000 ppm (in finished product form) or up to 5% in concentrated formulations.
The amount employed will also vary somewhat depending upon the exact material employed. The most active materials appear to be those having a dimethyl n-octyl ammonium salt configuration. Interestingly, as one increases or decreases the "long" group chain length say to C4 or C12 the activity falls off. At the "trimethyl" or "dimethyloctadecyl" extremes, antimicrobial a-ctivity is essentially absent. In general terms, this activity is as shown in Table I.
Figure imgf000015_0001
The antimicrobial formulations are prepared by conventional means of admixing, grinding and the like. In this regard, the polymers can be considered to be like other water-soluble salts and may be treated accordingly. No special formulation techiques are usually required.
The invention will be further described by the following examples. These are provided for purposes of illustration and are not to be considered as limiting the invention's scope.
EXAMPLE I
A. Preparation of Poly(chloromethyl styrene). AIBN (3.8 g, 23.1 mmoles) and 100 ml of toluene were charged to a magnetically-stirred reactor flask. Then 152.5 g (1.00 mole) of chloromethylstyrene was added with toluene to give a 900 ml reaction volume. Argon gas was bubbled through the mixture and it was heated in an oil bath to 78-80°. It was stirred for 22 hours at this temperature and then cooled. The polymer was recovered by adding hexane and dropping the mixture into 1.5 1 of hexane. A taffy-like precipitate formed, was collected, was rinsed in water, redissolved in THF, filtered, precipitated in petroleum ether, redissolved in THF and finally precipitated in methanol. The precipitate was collected and vacuum dried for nine hours at 60°C. The product was a powder having an average molecular weight by qel permeation chromatography comparison with polystyrene of 6.4 X 103.
B. Coupling of Trialkyl Amine. A solution of poly(chloromethylstyrene) (prepared in step A); (1.52 g, 10 mmole) in 50 ml of a one-to-one mixture of tetrahydrofuran and isopropanol was heated to reflux with stirring. Dimethyloctylamine (1.14 g, 7.25 mmole) was added and the reaction mixture was refluxed for 24 hours. This yielded the partially substituted poly(chloromethylstyrene) of the average formula
Figure imgf000016_0001
This product was not isolated. The entire reaction product was employed in step C.
C. Addition of Trialkanolamine. Triethanolamine (2.0 g, 13.4 mmole) was added to the reaction product of Part B, followed by 30 ml of isopropanol. The reaction mixture was then refluxed another 24 hours. At the conclusion of this reaction period, the homogeneous mixture was cooled, diluted to three times its original volume with water, and the volatile constituents removed by in vacuo distillation (rotary evaporator). The residue, after concentration to one-half volume, was diluted with three volumes of 20% aqueous isopropanol and .ultrafiltered through a 10,000 molecular-weight-cutoff cartridge (Amicon H1P10) with ten diavolumes of deionized water. The retentate was then concentrated by ultrafiltration to 100 ml and lyophilized to yield 2.46 g fluffy white solid of the formula
Figure imgf000017_0001
EXAMPLE II
A solution of polychloromethylstyrene of Part A, Example I (1.52 g, 10 mmole) in 50 ml of one to-one mixture of tetrahydrofuran and isopropanol was heated to reflux with stirring. Dimethyl hexylamine (1.42 g, 11 mmole) was added and the reaction mixture was refluxed 18 hours. After cooling, the homogeneous reaction mixture was diluted with water to three times its original volume, and the volatile constituents removed by distillation in vacuo (rotary evaporator). The residue after concentration by one-half was diluted with three volumes of water and ultrafiltered with deionized water (ten diavolumes) using a 10,000 molecular weight cutoff cartridge (Amicon H1P10). Lyophilization afforded 2.6 g of fluffy white solid of the formula
Figure imgf000018_0001
' Cl-
EXAMPLES III-VI and Comparative Experiments 1 and 2
The preparation of Example I was repeated substituting for dimethyloctylamine in equivalent amounts as follows:
Comparative Experiment 1 trimethylamine Comparative Experiment 2 dimethylethylamine Example III dimethyl-n-butylamine Example IV dimethy1-n-hexylamine Example V dimethyl-n-decylamine Example VI dimethyl-n-dodecylamine Example VII dimethyltetradecylamine Example VIII dimethylhexadecylamine Comparative Experiment 3 dimethyloctadecylamine
Additional Illustrative Embodiments (A-O)
The preparations of Examples I and II are each repeated four times with the following changes:
A. In place of DP 38-45 poly(vinylbenzylchloride), a 38-45 DP poly(vinylbenzylbromide) prepared by polymerizing vinylbenzylbromide, is employed as precursor polymer. B. In place of DP 38-45 poly(vinylbenzyl chloride) an equal weight of DP 10-12 poly (vinylbenzylchloride) prepared by increasing the amount of initiator is employed as precursor polymer.
C. and D. In place of DP 38-45 poly(vinylbenzylchloride) equal weights of DP 100-125 and DP 300-350 ρoly(vinylbenzylchloride) are employed as precursor polymer.
E.-L. In place of DP 38-45 poly(vinylbenzylchloride) the following copolymers, prepared by free-radical copolymerizing the requisite monomers, are used in amounts to provide 10 mmole of available vinylbenzylchloride
Ξ. 1:1 ratio vinylbenzylchloride: styrene
F. 1:1 ratio vinylbenzylchloride: butadiene
G. 1:0, .5 ratio vinylbenzylchloride: vinylacetamide
H. 1:1 ratio vinylbenzylchloride: acrylamide
I. 1:0, , 5 ratio vinylbenzyldimethyloctyl ammonium chloride: 4- vinylpyridine
J. 1:1 ratio vinylbenzyldimethyloctyl ammonium chloride: 4- vinylpyridine
K. 1:0.5 ratio vinylbenzyldimethyloctyl ammonium chloride: N- vinylimidazole
L. 1:0.5 ratio vinylbenzylchloride: n-dodecyl-4 vinyl pyridinium chloride M. The preparation of Example I is repeated substituting trimethylamine for triethanolamine.
Formulation of Antimicrobial Preparations
The quaternary ammonium group-containing products of the Examples and Illustrative Embodiments are formulated into antimicrobial preparations as follows :
Antimicrobial Solutions:
A typical antimicrobial solution is prepared by dissolving 0.5% by weight of the product of Example I in sterile water, in a 25%/75% isopropanol/sterile water mixture, in a sterile saline solution adjusted to give isotonicity, and in an isotonic contact lens wetting solution containing 1% by weight poly(vinylalcohol).
An antimicrobial cleansing composition comprising 10% of the dry polymer of Example II and 90% powdered surfactant is prepared. When this composition is dissolved in water an antimicrobial solution results .
An antimicrobial salve is formulated by admixing 1% of the powder of Example I in a pharmaceutically acceptable poly saccharride gel.
Antimicrobial Testing The materials of Examples I, II, III, IV, V, and VI were tested for antimicrobial activity. For purposes of comparison, Zephiran© (a commercially accepted antimicrobial) and comparative materials 1, 2 and 3 were also evaluated. Two basic test methods were used. A. Broth dilution test. Dilutions of the test materials (10,25,50,100,250 ppm) or Zephiran® (1,2,5,10,20 ppm) were prepared in 10 ml nutrient broth (BBL) (NB), or trypticase soy broth (TSB), innoculated with about 10° CFU/ml Pseudomonas aeruginosa 15442, and incubated at 36ºC for seven days. MIC (Minimum Inhibition Concentration) is the lowest concentration resulting in no visible growth.
B. Effectiveness in saline. Test materials were added to sterile 0.9% NaCl to give 100 ppm solutions (0.01%). Zephiran® was tested at 10 and 100 ppm. Tubes were innoculated with Pseudomonas aeruginosa 15442 at 2.7 X 106CFU ml-1 and incubated at 24°C. At 0.17, 0.5, 1, 2, 4, 6, 24, 48 and 72 hours after innoculation a loopful (1mm loop) was removed an transferred to 10 ml trypticase soy broth, vortexed, and incubated at 35° for up to seven days. Cidal time is the time of the first sample showing no growth in the recovery media. These two tests were repeated using other bacterial strains, as well.
With the material of Example I, the results shown in Table II were achieved. (For comparison, results with Zephiran are given as well.
Figure imgf000022_0001
Figure imgf000023_0001
The Broth test with Pseudomonas aeruginosa sing other materials:
Cidal Time in
Broth Dilution Test Saline Test Material MIC, ppm @100 ppm (hours) Example III >250 >48 Example IV <50 0.17 Example V <100 0.6 Example VI <250 4 Comparative 1 >250 >48 Comparative 2 >250 >48 Comparative 3 >250 24

Claims

Claims
1. An antimicrobial composition comprising an hygienically acceptable carrier having in admixture an effective antimicrobial concentration of a poly meriσ quaternary ammonium compound having recurring structural units of the formula
Figure imgf000025_0001
wherein R is a 4 to 12 atom alkyl, X" is a physiologically acceptable anion and R' and R'' are independently selected from the group of alkyls of from 1 to 4 carbon atoms.
2. The composition of Claim 1 wherein R' and R'' independently are one or two carbon alkyls.
3. The composition of Claim 2 Wherein R is a six carbon normal alkyl.
4. The composition of Claim 2 wherein R is an eight carbon normal alkyl.
5. The composition of Claim 4 wherein R' and R' ' are each methyls.
6. The composition of Claim 2 Wherein R is a ten carbon normal alkyl.
7. The composition of Claim 6 wherein R' and R' ' are each methyls.
8. A compound of the formula
Figure imgf000026_0001
R"
wherein R is a 6 to 10 carbon atom alkyl and R' and R'' are independently 1 to 4 carbon atom alkyls, X- is a physiologically acceptable anion, CU is selected from the group consisting of )-
Figure imgf000026_0002
r - N+ - r'' X- l r' wherein r, r' and r' ' are independently selected from the group consisting of alkanols of from 1 to 4 carbon atoms and alkyls of 1 to 4 carbon atoms , and
Figure imgf000027_0001
wherein y is from 1 to 10 inclusive and R' ' ' is selected from the group consisting of hydrogen and alkyls of 1 to 4 carbon atoms, and n and m are integers totalling from 20 to 10,000 with m being from 0.2 to 0.9 times the sum of n plus m.
9. The compound of Claim 8 wherein CU has the structural formula
Figure imgf000027_0002
wherein r, r ' and r ' ' are independently selected from alkanols of from 1 to 4 carbons and methyls .
10. The compound of Claim 9 wherein r, r ' and r ' ' are each methyls .
11. The compound of Claim 8 having the structural formula 3
Figure imgf000028_0001
wherein q is 2 to 4.
12. The compound of Claim 14 wherein R is n-octyl, R' and R'' are methyl and q is 2.
13. The compound of Claim 15 wherein m is from 0.2 to 0.9 times the sum of n plus m.
14. The compound of Claim 8 having the structural formula
Figure imgf000028_0002
wherein R is -n-octyl, R' and R'' are each methyl, y is from 1 to 10 inclusive and R' ' ' is hydrogen or a 1 through 4 carbon atom alkyl.
15. An antimicrobial composition comprising a hygienically acceptable carrier having in admixture therewith an effective antimicrobial concentration of a polymeric quaternary ammonium compound of Claim 8.
16. An antimicrobial composition carrier having in admixture therewith an effective antimicrobial concentration of a polymeric quaternary ammonium compound of Claim 11.
PCT/US1982/001244 1981-09-15 1982-09-14 Quaternary ammonium group-containing polymers having antimicrobial activity WO1983001002A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30268481A 1981-09-15 1981-09-15
US302,684810915 1981-09-15

Publications (1)

Publication Number Publication Date
WO1983001002A1 true WO1983001002A1 (en) 1983-03-31

Family

ID=23168788

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1982/001244 WO1983001002A1 (en) 1981-09-15 1982-09-14 Quaternary ammonium group-containing polymers having antimicrobial activity

Country Status (2)

Country Link
EP (1) EP0087473A4 (en)
WO (1) WO1983001002A1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322209A1 (en) * 1987-12-23 1989-06-28 Smith Kline & French Laboratories Limited Compounds
EP0385686A2 (en) * 1989-02-28 1990-09-05 Smith Kline & French Laboratories Limited Compounds
EP0403271A2 (en) * 1989-06-15 1990-12-19 Smith Kline & French Laboratories Limited Polymer compounds
EP0403198A2 (en) * 1989-06-14 1990-12-19 Smith Kline & French Laboratories Limited Compounds
EP0403199A2 (en) * 1989-06-14 1990-12-19 Smith Kline & French Laboratories Limited Compounds
WO1993012820A1 (en) * 1991-12-23 1993-07-08 Ciba-Geigy Ag Method of imparting antimicrobial activity to an ophthalmic composition
EP0554029A1 (en) * 1992-01-27 1993-08-04 Sunstar Kabushiki Kaisha Oral compositions
EP0604369A1 (en) * 1992-12-23 1994-06-29 Ciba-Geigy Ag Deposit-resistant contact lenses
WO1997049413A1 (en) * 1996-06-24 1997-12-31 Geltex Pharmaceuticals, Inc. Ionic polymers as anti-infective agents
US6007803A (en) * 1997-09-19 1999-12-28 Geltex Pharmaceuticals, Inc. Ionic polymers as toxin binding agents
US6290947B1 (en) 1997-09-19 2001-09-18 Geltex Pharmaceuticals, Inc. Ionic polymers as toxin-binding agents
US6482402B1 (en) 1999-05-13 2002-11-19 Geltex Pharmaceuticals, Inc. Antimicrobial compositions and methods

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2772310A (en) * 1955-05-13 1956-11-27 Dow Chemical Co Aralkyl quaternary ammonium bases and salts
US3898088A (en) * 1973-09-26 1975-08-05 Eastman Kodak Co Photographic elements containing polymeric mordants
US3931319A (en) * 1974-10-29 1976-01-06 Millmaster Onyx Corporation Capped polymers
US3944424A (en) * 1973-09-26 1976-03-16 Eastman Kodak Company Photographic or image recieving elements containing polymeric mordants
US3963662A (en) * 1973-03-13 1976-06-15 Maruzen Oil Co. Ltd. Polyion complex and process for preparation thereof
US4087599A (en) * 1976-08-19 1978-05-02 The Dow Chemical Company Preparation of a water-soluble polyvinylbenzyl quaternary ammonium halide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1461909A (en) * 1973-08-21 1977-01-19 Ici Ltd Biocidal compositions

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2772310A (en) * 1955-05-13 1956-11-27 Dow Chemical Co Aralkyl quaternary ammonium bases and salts
US3963662A (en) * 1973-03-13 1976-06-15 Maruzen Oil Co. Ltd. Polyion complex and process for preparation thereof
US3898088A (en) * 1973-09-26 1975-08-05 Eastman Kodak Co Photographic elements containing polymeric mordants
US3944424A (en) * 1973-09-26 1976-03-16 Eastman Kodak Company Photographic or image recieving elements containing polymeric mordants
US3931319A (en) * 1974-10-29 1976-01-06 Millmaster Onyx Corporation Capped polymers
US4087599A (en) * 1976-08-19 1978-05-02 The Dow Chemical Company Preparation of a water-soluble polyvinylbenzyl quaternary ammonium halide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP0087473A4 *

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989005828A1 (en) * 1987-12-23 1989-06-29 Smith Kline & French Laboratories Limited Compounds
EP0322209A1 (en) * 1987-12-23 1989-06-28 Smith Kline & French Laboratories Limited Compounds
EP0385686A3 (en) * 1989-02-28 1992-02-12 Smith Kline & French Laboratories Limited Compounds
EP0385686A2 (en) * 1989-02-28 1990-09-05 Smith Kline & French Laboratories Limited Compounds
EP0403199A3 (en) * 1989-06-14 1992-02-12 Smith Kline & French Laboratories Limited Compounds
EP0403199A2 (en) * 1989-06-14 1990-12-19 Smith Kline & French Laboratories Limited Compounds
EP0403198A3 (en) * 1989-06-14 1992-02-12 Smith Kline & French Laboratories Limited Compounds
EP0403198A2 (en) * 1989-06-14 1990-12-19 Smith Kline & French Laboratories Limited Compounds
EP0403271A3 (en) * 1989-06-15 1992-02-12 Smith Kline & French Laboratories Limited Polymer compounds
EP0403271A2 (en) * 1989-06-15 1990-12-19 Smith Kline & French Laboratories Limited Polymer compounds
WO1993012820A1 (en) * 1991-12-23 1993-07-08 Ciba-Geigy Ag Method of imparting antimicrobial activity to an ophthalmic composition
US5348738A (en) * 1992-01-27 1994-09-20 Sunstar Kabushiki Kaisha Oral composition with active water insoluble polymer
EP0554029A1 (en) * 1992-01-27 1993-08-04 Sunstar Kabushiki Kaisha Oral compositions
EP0604369A1 (en) * 1992-12-23 1994-06-29 Ciba-Geigy Ag Deposit-resistant contact lenses
WO1997049413A1 (en) * 1996-06-24 1997-12-31 Geltex Pharmaceuticals, Inc. Ionic polymers as anti-infective agents
US6034129A (en) * 1996-06-24 2000-03-07 Geltex Pharmaceuticals, Inc. Ionic polymers as anti-infective agents
AU727732B2 (en) * 1996-06-24 2000-12-21 Genzyme Corporation Ionic polymers as anti-infective agents
US6395777B2 (en) 1996-06-24 2002-05-28 Geltex Pharmaceuticals, Inc. Ionic polymers as anti-infective agents
US6593366B2 (en) 1996-06-24 2003-07-15 Geltex Pharmaceuticals, Inc. Ionic polymers as anti-infective agents
US6767549B2 (en) 1996-06-24 2004-07-27 Genzyme Corporation Ionic polymers as anti-infective agents
US6007803A (en) * 1997-09-19 1999-12-28 Geltex Pharmaceuticals, Inc. Ionic polymers as toxin binding agents
US6290947B1 (en) 1997-09-19 2001-09-18 Geltex Pharmaceuticals, Inc. Ionic polymers as toxin-binding agents
US6692732B2 (en) 1997-09-19 2004-02-17 Genzyme Corporation Ionic polymers as toxin-binding agents
US6482402B1 (en) 1999-05-13 2002-11-19 Geltex Pharmaceuticals, Inc. Antimicrobial compositions and methods

Also Published As

Publication number Publication date
EP0087473A1 (en) 1983-09-07
EP0087473A4 (en) 1984-02-09

Similar Documents

Publication Publication Date Title
US4482680A (en) Quaternary ammonium group-containing polymers having antimicrobial activity
US4532128A (en) Quaternary ammonium group-containing polymers having antimicrobial activity
US5358688A (en) Antimicrobial quaternary ammonium group-containing polymers, compositions thereof, and monomers used to produce said polymers
Kawabata et al. Antibacterial activity of soluble pyridinium-type polymers
Abdel-Mohsen et al. Eco-synthesis of PVA/chitosan hydrogels for biomedical application
WO1983001002A1 (en) Quaternary ammonium group-containing polymers having antimicrobial activity
EP0200903B1 (en) Polymeric antibacterial compositions
CA1142297A (en) Compounds of sterilizing activity
CN1089587C (en) Stable cross-linked compound of polyvinyl pyrrolidone and iodine and method for preparation of said compound
JPS6119273B2 (en)
CA1176985A (en) Copolymers having bactericidal activity, process for the preparation thereof and pharmaceutical compositions therefrom
JPH09510749A (en) Use of Polyethylene Oxide-Containing Polymeric Quaternary Ammonium Compounds in Pharmaceutical Compositions
EP1732973A1 (en) Crosslinked polymers containing biomass derived materials
US5348738A (en) Oral composition with active water insoluble polymer
EP0090577B1 (en) Insoluble polymeric contact preservatives
DE69728862T2 (en) ANTIVIRAL BASE MATERIAL
CN114569473B (en) Environment-friendly wash-free antibacterial gel and preparation method thereof
CA2352079A1 (en) Amido polybiguanides and the use thereof as antimicrobial agents
GB2027040A (en) Polymers of diallylamine quaternary salts: sterilizing agents
JP3096528B2 (en) Oral composition
CN116568272A (en) Soluble polyelectrolyte complexes of polymeric biguanide microbiocides and glycosaminoglycans
WO2022219944A1 (en) Anti-coronavirus agent
JP3407829B2 (en) Oral composition
JPH02237903A (en) Microorganic adsorbent
JPH02235802A (en) Adsorbent of microorganism

Legal Events

Date Code Title Description
AK Designated states

Designated state(s): JP

AL Designated countries for regional patents

Designated state(s): AT BE CH DE FR GB LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1982903009

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1982903009

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1982903009

Country of ref document: EP